age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
83.64398
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 0
| 14,988
| 10,007.9531
| 10,994.6094
| 18
|
white
| 25.5
| 31
| 0.570923
| 0.459961
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.6
|
no dnr
| 12
| 116
| 9.798828
| 66
| 32
| 36
| 242.5
| 1.399902
| 0.699951
| 2.099609
| 139
| 7.349609
| 170
| 18
| 1,795
| 0
| 3
|
no(M2 and SIP pres)
| 3
| 819
| 0
|
76.56396
|
male
| 1
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 6
| 20
|
$11-$25k
| 41
| 3,525
| 2,471.7988
| 3,008.38867
| 30
|
white
| 31.097656
| 76
| 0.181976
| 0.050995
| 1
| 0
| 0
|
no
| null | null |
dnr before sadm
| 0
| 107
| 20.699219
| 103
| 34
| 35.59375
| 167.5
| 2.199707
| 0.399963
| 1.299805
| 142
| 7.359375
| 157
| 12
| 5,360
| null | 2
|
<2 mo. follow-up
| 2
| 4
| 1
|
70.94897
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 53,884
| 34,887.6562
| 41,764.2812
| 42.333313
|
white
| 27.5
| 31
| 0.670898
| 0.574951
| 6
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 18
| 58
| 22.097656
| 122
| 38
| 38.29688
| 176.65625
| 2.099609
| 0.699951
| 5.299805
| 145
| 7.439453
| 138
| 68
| 617
| null | 0
|
no(M2 and SIP pres)
| 0
| 820
| 0
|
44.112
|
male
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 5,430
| 3,820.9727
| 4,681.81641
| 3
|
white
| 29.398438
| 26
| 0.730957
| 0.578979
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 6
| 63
| 6.5
| 61
| 24
| 36.19531
| 309.5
| 1.899902
| 0.699951
| 1.199951
| 142
| 7.539062
| 113
| 39
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 369
| 1
|
28.523
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 5,666
| 3,811.1543
| 4,416.05859
| 15
|
white
| 16.296875
| 12
| 0.794922
| 0.565918
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 4
| 95
| 9.699219
| 69
| 20
| 36.29688
| 442.8125
| 4.099609
| 1
| 1.099854
| 136
| 7.449219
| 123
| 10
| 2,900
| null | 0
| null | 0
| 708
| 1
|
43.603
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 5,065
| 2,676.707
| 3,611.36914
| null |
white
| 13.599609
| 14
| 0.945923
| 0.908936
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 70
| 8.298828
| 176
| 20
| 37.89844
| null | 4
| 1
| 0.799927
| 134
| null | 94
| 14
| 1,500
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 817
| 0
|
79.55597
|
male
| 0
| 35
|
Coma
|
Coma
| 0
| 16
|
$11-$25k
| 9
| 68,866
| 45,992.9688
| 49,307.1562
| 21
|
hispanic
| 16.597656
| 43
| 0.641968
| 0.580933
| 6
| 0
| 0
|
no
| 0.67
| 0.7
|
no dnr
| 35
| 85
| null | 114
| 24
| 36.09375
| 136
| null | null | 0.899902
| 136
| 7.299805
| 129
| 9
| 2,175
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 98
| 1
|
62.29199
|
male
| 0
| 3
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 2,223
| 1,608.5732
| 1,986.05957
| null |
white
| 16.097656
| 18
| 0.791992
| 0.665894
| 1
| 0
| 0
|
yes
| 0.9
| 0.8
|
no dnr
| 3
| 122
| 10.199219
| 109
| 24
| 35.69531
| 229.625
| 3.799805
| 0.799927
| 0.799927
| 136
| 7.30957
| 120
| 14
| 1,900
| null | null |
no(M2 and SIP pres)
| 2.431152
| 817
| 0
|
90.52399
|
female
| 1
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 5
|
under $11k
| 0
| 6,025
| 4,134.9375
| 4,368.52734
| 6
|
white
| 16.296875
| 34
| 0.822998
| 0.712891
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
dnr after sadm
| 6
| 144
| 14.298828
| 138
| 13
| 36.69531
| 134.65625
| 2.099609
| 1.699951
| 5.199219
| 134
| 7.269531
| 178
| 63
| 1,126
| 1
| 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
64.16699
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 14
|
under $11k
| 0
| 2,727
| 0
| 0
| 10
|
black
| 28
| 41
| 0.756958
| 0.61499
| 1
| 1
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 4
| 101
| 3.899902
| 68
| 24
| 36.79688
| 466.625
| 2.899902
| 4.299805
| 0.699951
| 138
| 7.389648
| 92
| 5
| null | 3
| 5
|
no(M2 and SIP pres)
| 5
| 813
| 0
|
65.34998
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 3
| 12
|
$11-$25k
| 9
| 3,482
| 2,540.1289
| 3,109.50977
| 13
|
white
| 14.599609
| 9
| 0.723999
| 0.448975
| 1
| 1
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 5
| 123
| 0.699951
| 140
| 32
| 35.89844
| null | null | null | 4.199219
| 130
| null | 119
| 42
| null | null | 4
|
<2 mo. follow-up
| 4
| 44
| 1
|
54.40399
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| 12
|
under $11k
| 9
| 6,504
| 4,654.293
| 5,790.12891
| 6
|
white
| 11.099609
| 19
| 0.802979
| 0.580933
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
dnr before sadm
| -1
| 112
| 26.199219
| 140
| 12
| 38.5
| 222.5
| 1.399902
| 3.899902
| 0.699951
| 139
| 7.40918
| 194
| 7
| 2,250
| 0
| 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
58.995
|
male
| 0
| 26
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 8
|
under $11k
| 9
| 45,541
| 30,684.9844
| 36,930.7188
| 28.25
|
white
| 37.796875
| 29
| 0.532959
| 0.333984
| 1
| 1
| 0
|
no
| 0.8
| 0.65
|
no dnr
| 26
| 118
| null | 53
| 28
| 38.29688
| 313.3125
| 1.599854
| 1.099854
| 2
| 145
| 7.459961
| 109
| 39
| 4,210
| 0
| 0
|
SIP>=30
| 0
| 810
| 0
|
55.702
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 7
|
$11-$25k
| 0
| 10,151
| 6,042.293
| 6,985.70703
| 14.5
|
white
| 21.796875
| 20
| 0.860962
| 0.812988
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 7
| 89
| 10.5
| 79
| 20
| 36
| null | 3.699707
| 1
| 2
| 138
| null | 113
| 45
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 84
| 1
|
77.49799
|
female
| 1
| 6
|
Coma
|
Coma
| 0
| 10
|
under $11k
| 44
| 14,161
| 9,069.25
| 10,322.1797
| 52
|
white
| 22
| 54
| 0.42395
| 0.350952
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 1
| 113
| 17.097656
| 152
| 10
| 39.79688
| 190
| null | null | 0.899902
| 143
| 7.429688
| 176
| 22
| 3,695
| null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
40.93399
|
male
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 6,717
| 4,903.5938
| 5,247.82812
| 8
|
white
| 15.898438
| 27
| 0.908936
| 0.846924
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 8
| 107
| 10.5
| 121
| 9
| 36.5
| 184
| 2.399902
| 1
| 1.299805
| 132
| 7.429688
| 233
| 16
| 4,575
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 804
| 0
|
74.146
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 3,434
| 1,934.5312
| 2,030.45996
| 12
|
white
| 16.5
| 19
| 0.871948
| 0.786987
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 4
| 116
| 6.5
| 116
| 24
| 36.39844
| 224.96875
| 3.199707
| 0.899902
| 0.5
| 130
| 7.459961
| 102
| 4
| 3,075
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 803
| 0
|
34.64798
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 100
| 49,625
| 30,662.9688
| 34,789.4688
| null |
white
| 42.695313
| 98
| 0.043999
| 0.012999
| 14
| 0
| 0
|
no
| 0.2
| 0.2
|
no dnr
| 3
| 103
| 21.796875
| 85
| 20
| 36.19531
| null | 3.099609
| 0.599976
| 13.398438
| 140
| null | 151
| 83
| 2,450
| null | 5
|
<2 mo. follow-up
| 5
| 3
| 1
|
74.19299
|
male
| 0
| 15
|
Colon Cancer
|
Cancer
| 1
| 20
|
under $11k
| 0
| 11,182
| 8,331.7891
| 11,199.0781
| 10.666664
|
white
| 15.5
| 19
| 0.819946
| 0.611938
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.4
|
dnr after sadm
| 13
| 65
| 7.299805
| 64
| 20
| 36.09375
| null | 4.299805
| 0.599976
| 1
| 138
| 7.419922
| 261
| 22
| 2,475
| 1
| null |
SIP>=30
| 1.166748
| 176
| 1
|
84.10394
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 41,670
| 25,552.9531
| 30,203.75
| 62
|
white
| 35.59375
| 74
| 0.451965
| 0.332947
| 1
| 0
| 0
|
no
| 0.4
| 0.35
|
dnr after sadm
| 8
| 96
| 4.899414
| 65
| 20
| 36.5
| null | 2.599609
| 4.299805
| 0.599976
| 140
| null | 80
| 7
| 860
| null | null |
<2 mo. follow-up
| 2.975098
| 11
| 1
|
69.71899
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 14,225
| 7,411.1992
| 9,426.57812
| 10.5
|
white
| 20.097656
| 57
| 0.845947
| 0.746948
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 7
| 104
| 12
| 130
| 26
| 35.5
| 257.125
| 3.099609
| 0.599976
| 1
| 141
| 7.339844
| 202
| 7
| 1,475
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 799
| 0
|
65.66998
|
male
| 1
| 13
|
Coma
|
Coma
| 0
| 11
|
under $11k
| 44
| 34,190
| 21,498.0781
| 24,579.3906
| 43
|
white
| 17.796875
| 34
| 0.623901
| 0.56189
| 2
| 0
| 0
|
no
| 0.4
| 0.35
|
dnr after sadm
| 11
| 153
| 11.298828
| 63
| 24
| 36.79688
| 153.03125
| 2.299805
| 0.799927
| 1.299805
| 142
| 7.329102
| 96
| 24
| 5,565
| null | 0
|
<2 mo. follow-up
| 0
| 13
| 1
|
85.48895
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 5
|
under $11k
| 9
| 13,746
| 9,013.9375
| 9,537.88281
| 9.5
|
white
| 17
| 36
| 0.81189
| 0.694946
| 1
| 1
| 1
|
no
| 0.8
| 0.6
|
no dnr
| 13
| 121
| 11.298828
| 147
| 34
| 40
| 202
| 3.299805
| 0.599976
| 0.899902
| 143
| 7.529297
| 398
| 14
| 2,183
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 147
| 1
|
52.22198
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 9,511
| 6,064.7969
| 6,643.25781
| 11
|
black
| 11.398438
| 20
| 0.954956
| 0.921997
| 1
| 0
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 9
| 123
| 11.398438
| 124
| 36
| 38.79688
| 215
| 3.099609
| 1
| 1.399902
| 160
| 7.5
| 183
| 24
| 2,885
| 1
| 1
|
no(M2 and SIP pres)
| 1
| 799
| 0
|
61.59097
|
female
| 0
| 174
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 528,991
| 343,305.25
| 393,421.25
| 53.5
|
white
| 31.5
| 56
| 0.656982
| 0.557983
| 3
| 0
| 0
|
no
| 0.5
| 0.75
|
no dnr
| 174
| 116
| 15.699219
| 122
| 42
| 36.69531
| 126.65625
| 2.5
| 0.199982
| 0.699951
| 141
| 7.489258
| 78
| 8
| 9,000
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 798
| 0
|
87.44696
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 10
|
under $11k
| 9
| 3,190
| 2,298.9609
| 2,387.2793
| 7
|
white
| 14.099609
| 31
| 0.841919
| 0.740967
| 1
| 1
| 1
|
no
| null | null |
no dnr
| 4
| 54
| 18.597656
| 117
| 35
| 39.5
| 328.5625
| 2
| 3.199707
| 3.5
| 130
| 7.359375
| 187
| 44
| 853
| null | null |
adl>=4 (>=5 if sur)
| 5.142578
| 248
| 1
|
74.64496
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 3
| 9
| null | 0
| 5,841
| 3,918.9316
| 5,393.25781
| 15
|
white
| 17
| 32
| 0.684937
| 0.391968
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.2
|
dnr after sadm
| 2
| 57
| 22.898438
| 63
| 8
| 35.69531
| 325.6875
| 2.899902
| 0.899902
| 12
| 137
| 7.399414
| 117
| 154
| 0
| 0
| 0
| null | 0
| 70
| 1
|
70.85797
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 15,318
| 9,469.1094
| 10,553.8125
| 29
|
white
| 28.796875
| 50
| 0.69397
| 0.528931
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 9
| 71
| 14.099609
| 119
| 8
| 38.5
| 115
| 1.699951
| 2.5
| 0.5
| 126
| 7.529297
| 122
| 15
| 1,478
| 6
| 3
|
SIP>=30
| 3
| 795
| 0
|
38.54898
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 0
| 19,873
| 12,585.9062
| 12,943.2969
| 25
|
white
| 23.796875
| 27
| 0.860962
| 0.81189
| 4
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 6
| 69
| 9.398438
| 130
| 28
| 36.59375
| 134.6875
| 2.899902
| 1.5
| 0.699951
| 137
| 7.40918
| 74
| 14
| 2,368
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 795
| 0
|
77.29498
|
male
| 1
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
|
under $11k
| 37
| 99,954
| 64,701.1562
| 76,104.625
| 52.5
|
white
| 27.699219
| 48
| 0.535889
| 0.420959
| 1
| 1
| 0
|
no
| 0.05
| 0
|
dnr after sadm
| 30
| 68
| 15.298828
| 107
| 30
| 36.59375
| null | 2.699707
| 0.799927
| 0.799927
| 136
| null | 286
| 6
| 2,050
| null | 7
|
<2 mo. follow-up
| 7
| 33
| 1
|
44.34998
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 12
|
under $11k
| 0
| 5,294
| 0
| 0
| 13
|
black
| 28.699219
| 21
| 0.482971
| 0.163971
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 2
| 118
| 6.899414
| 61
| 22
| 36.59375
| 460
| 1.5
| 0.399963
| 3.699707
| 133
| 7.40918
| 383
| 50
| 2,646
| 6
| 6
|
<2 mo. follow-up
| 6
| 42
| 1
|
64.91699
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
| null | 0
| 42,535
| 27,290.4375
| 30,593.1562
| 37
|
white
| 26.398438
| 47
| 0.74292
| 0.661987
| 3
| 0
| 0
|
no
| 0.5
| 0.45
|
no dnr
| 22
| 131
| 9.798828
| 77
| 43
| 36.29688
| 202.5
| 2.699707
| 1.599854
| 0.5
| 149
| 7.539062
| 119
| 12
| 3,795
| null | 0
|
no(M2 and SIP pres)
| 0
| 794
| 0
|
71.81396
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
|
under $11k
| 0
| 17,482
| 11,167.8828
| 12,565.5391
| 38
|
white
| 23.296875
| 45
| 0.793945
| 0.725952
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 10
| 80
| 11.898438
| 101
| 32
| 37.5
| 252.375
| 2.899902
| 0.199982
| 1.199951
| 137
| 7.429688
| 87
| 18
| 2,675
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 790
| 0
|
82.91296
|
female
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
under $11k
| 37
| 17,620
| 9,559.0625
| 11,777.9141
| 18.5
|
white
| 26.5
| 41
| 0.363953
| 0.245972
| 5
| 1
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 4
| 82
| 5.5
| 85
| 24
| 36.39844
| null | 3.799805
| 0.399963
| 1
| 137
| null | 141
| 13
| 6,625
| null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
76.646
|
female
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 3,833
| 2,677.7578
| 4,130.22656
| 5
|
white
| 17.097656
| 9
| 0.793945
| 0.563965
| 1
| 0
| 0
|
metastatic
| 1
| 0.8
|
no dnr
| 4
| 69
| 5
| 118
| 24
| 36.79688
| 161.65625
| 2.599609
| 3.099609
| 0.699951
| 135
| 7.379883
| 96
| 6
| 1,890
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 790
| 0
|
60.70398
|
female
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 9
|
$11-$25k
| 0
| 7,557
| 5,053.4688
| 6,265.11719
| 11
|
white
| 13.599609
| 9
| 0.822998
| 0.710938
| 2
| 1
| 0
|
yes
| 0.8
| 0.6
|
no dnr
| 4
| 85
| 6.599609
| 88
| 24
| 37
| 270.3125
| null | null | 1.199951
| 137
| 7.399414
| 118
| 25
| 100
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 790
| 0
|
62.71899
|
female
| 1
| 3
|
Coma
|
Coma
| 0
| 8
|
$25-$50k
| 100
| 6,113
| 3,972.3184
| 4,416.71875
| 34
|
white
| 49.398438
| 90
| 0
| 0
| 1
| 0
| 0
|
no
| 0.1
| 0
|
dnr after sadm
| 2
| 45
| 17.597656
| 200
| 36
| 36.09375
| 114
| 1.899902
| 21.898438
| 2.599609
| 124
| 7.30957
| 34
| 12
| 144
| null | 1
|
<2 mo. follow-up
| 1
| 3
| 1
|
58.30798
|
male
| 0
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 9,487
| 6,871.7852
| 7,020.46875
| 10.5
|
white
| 23.398438
| 27
| 0.744995
| 0.598999
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 10
| 71
| 10.398438
| 76
| 24
| 35.79688
| 195
| 2.899902
| 2.299805
| 1.599854
| 134
| 7.429688
| 98
| 54
| 1,990
| 0
| 0
|
SIP>=30
| 0
| 789
| 0
|
79.12396
|
male
| 0
| 16
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 0
|
under $11k
| 9
| 17,993
| 13,135.5078
| 17,007
| 11.333328
|
white
| 30.097656
| 39
| 0.313965
| 0.200989
| 6
| 1
| 0
|
metastatic
| 0.5
| 0.1
|
dnr before sadm
| -1
| 84
| 6.199219
| 72
| 20
| 34.89844
| 228.5625
| 3.199707
| 2.199707
| 0.699951
| 132
| 7.389648
| 89
| 10
| 545
| 1
| 1
|
<2 mo. follow-up
| 1
| 42
| 1
|
74.724
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 9
| 26,976
| 17,403.8281
| 19,448.5625
| 31.333328
|
white
| 32.296875
| 72
| 0.56189
| 0.449951
| 1
| 0
| 0
|
no
| 0.35
| 0.3
|
dnr after sadm
| 1
| 102
| 43.195313
| 107
| 36
| 36.09375
| null | null | null | 3
| 138
| null | 94
| 33
| 1,950
| null | 5
|
<2 mo. follow-up
| 5
| 17
| 1
|
65.61499
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
>$50k
| 0
| 11,004
| 5,491.8789
| 7,059.65625
| 11
|
white
| 22.296875
| 27
| 0.833984
| 0.728882
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 7
| 102
| 6.399414
| 75
| 38
| 35.5
| 288.875
| 2.099609
| 0.899902
| 1.699951
| 141
| 7.429688
| 78
| 18
| 1,830
| 0
| 0
|
<2 mo. follow-up
| 0
| 25
| 1
|
75.24396
|
male
| 1
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
$25-$50k
| 44
| 81,024
| 53,595.125
| 56,399.625
| 32.5
|
white
| 24.796875
| 39
| 0.592896
| 0.483948
| 1
| 1
| 1
|
no
| 0.75
| 0.1
|
dnr after sadm
| 3
| 75
| 9.699219
| 76
| 16
| 36
| null | 2.099609
| 1.399902
| 0.699951
| 129
| null | 135
| 16
| null | null | 6
|
<2 mo. follow-up
| 6
| 46
| 1
|
67.28296
|
female
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 14
|
under $11k
| 0
| 10,817
| 7,378.5508
| 8,418.28906
| 12
|
white
| 13.898438
| 16
| 0.836914
| 0.733887
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 8
| 75
| 20.296875
| 68
| 10
| 38.09375
| 231.40625
| 4.299805
| 0.5
| 1
| 141
| 7.469727
| 107
| 16
| 704
| 0
| null | null | 0.494751
| 785
| 0
|
64.55298
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 6
|
under $11k
| 0
| 3,957
| 2,566.5977
| 2,682.63867
| 12
|
white
| 15.699219
| 7
| 0.903931
| 0.838989
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 4
| 111
| 8.298828
| 81
| 20
| 37.69531
| null | null | null | 1.099854
| 140
| null | 112
| 13
| null | 0
| null |
no(M2 and SIP pres)
| 0.494751
| 782
| 0
|
76.271
|
female
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
under $11k
| 26
| 22,169
| 14,495.5469
| 16,692.6094
| 37.5
|
white
| 23.898438
| 53
| 0.659912
| 0.562988
| 2
| 1
| 0
|
no
| 0.25
| 0.1
|
dnr after sadm
| 8
| 107
| 6.799805
| 74
| 20
| 35.29688
| 137.03125
| 4.199219
| 1.299805
| 1.899902
| 136
| 7.339844
| 158
| 63
| 1,485
| null | null |
<2 mo. follow-up
| 3.133789
| 8
| 1
|
74.93195
|
female
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 9
|
$11-$25k
| 0
| 9,535
| 6,474.2812
| 8,051.58984
| 23
|
white
| 28.796875
| 37
| 0.384949
| 0.188995
| 1
| 1
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 1
| 115
| 12.798828
| 111
| 11
| 36.59375
| 160
| 2.799805
| 3
| 4.099609
| 137
| 7.549805
| 159
| 42
| 747
| 2
| 3
|
<2 mo. follow-up
| 3
| 21
| 1
|
82.85596
|
female
| 0
| 20
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 5
|
under $11k
| 0
| 16,190
| 12,133.25
| 11,202.6172
| 6.666664
|
black
| 14.398438
| 38
| 0.859985
| 0.767944
| 2
| 1
| 0
|
no
| 0.8
| 0.7
|
dnr before sadm
| -1
| 68
| 10.898438
| 104
| 24
| 36
| 157.5
| 3.899902
| 0.899902
| 2
| 139
| 7.209961
| 202
| 76
| 1,675
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 780
| 0
|
63.63898
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 0
| 10,863
| 6,378.3438
| 7,041.32812
| 18
|
white
| 25.796875
| 29
| 0.784912
| 0.714966
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 8
| 117
| 11.099609
| 100
| 21
| 37.59375
| 203.6875
| 3.299805
| 0.599976
| 3.599609
| 146
| 7.439453
| 103
| 63
| 2,540
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 758
| 1
|
71.474
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 5
|
under $11k
| 0
| 8,004
| 5,895.2852
| 5,674.44922
| 11
|
black
| 18.597656
| 31
| 0.856934
| 0.764893
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 9
| 53
| 10.199219
| 66
| 28
| 37
| null | 2.099609
| 5.199219
| 3.099609
| 136
| null | 98
| 45
| 190
| null | 4
|
adl>=4 (>=5 if sur)
| 4
| 777
| 0
|
73.45398
|
female
| 1
| 57
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 37
| 171,216
| 108,781.875
| 120,742.625
| 39.5
|
white
| 20.199219
| 23
| 0.648926
| 0.54895
| 14
| 0
| 0
|
no
| 0.6
| 0.4
|
dnr after sadm
| 57
| 107
| 14.099609
| 140
| 10
| 38
| 140
| null | null | 0.899902
| 132
| 7.429688
| 86
| 13
| 2,913
| null | 1
|
<2 mo. follow-up
| 1
| 57
| 1
|
57.08398
|
female
| 1
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 9
| 119,689
| 78,583.4375
| 101,367.812
| 53.25
|
white
| 23.699219
| 53
| 0.710938
| 0.622925
| 9
| 0
| 0
|
yes
| 0.3
| 0.2
|
dnr after sadm
| 30
| 96
| 6.799805
| 130
| 20
| 36.5
| 400
| 2.099609
| 7.399414
| 0.599976
| 131
| 7.419922
| 148
| 6
| null | null | 1
|
<2 mo. follow-up
| 1
| 32
| 1
|
27.91499
|
male
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 0
| 51,737
| 34,929.4375
| 42,677.5625
| 29.75
|
white
| 26.597656
| 40
| 0.869995
| 0.823975
| 2
| 0
| 0
|
no
| 0.8
| 0.95
|
no dnr
| 32
| 75
| 6.299805
| 55
| 20
| 36.59375
| null | null | null | 0.899902
| 138
| null | 121
| 7
| 4,200
| null | 0
|
no(M2 and SIP pres)
| 0
| 775
| 0
|
43.31799
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
>$50k
| 0
| 3,774
| 2,671.8027
| 2,576.83984
| 13
|
white
| 25.898438
| 30
| 0.861938
| 0.771973
| 1
| 1
| 0
|
no
| 0.5
| 0.25
|
dnr before sadm
| -1
| 106
| 9.398438
| 53
| 22
| 36.39844
| null | 4.099609
| 1.099854
| 1
| 138
| null | 92
| 14
| 900
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 775
| 0
|
73.27594
|
female
| 1
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 4,532
| 2,593.2266
| 2,610.09961
| 20
|
white
| 24.597656
| 69
| 0.770996
| 0.635986
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 3
| 110
| 17.699219
| 68
| 10
| 38.29688
| 218
| null | null | 1.099854
| 132
| 7.439453
| 158
| 25
| 1.569824
| null | 7
|
<2 mo. follow-up
| 7
| 4
| 1
|
59.504
|
male
| 1
| 6
|
Coma
|
Coma
| 3
| 12
|
under $11k
| 100
| 28,075
| 18,682.875
| 23,228.4844
| 61
|
white
| 39
| 80
| 0
| 0
| 9
| 0
| 0
|
yes
| 0.02
| 0.01
|
dnr after sadm
| 2
| 87
| 2.699707
| 69
| 22
| 36.39844
| null | 2.199707
| 1.299805
| 0.899902
| 133
| null | 91
| 5
| null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
57.94699
|
female
| 0
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
under $11k
| 9
| 12,181
| 7,889.6992
| 10,269.0781
| 30
|
white
| 24.796875
| 30
| 0.585938
| 0.47699
| 1
| 1
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 8
| 64
| 5.5
| 69
| 24
| 35.89844
| null | 3.699707
| 0.299988
| 1.699951
| 138
| null | 93
| 64
| 1,275
| 4
| 6
|
SIP>=30
| 6
| 171
| 1
|
60.91699
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 6,069
| 4,591.3398
| 4,687.21875
| 9
|
white
| 23
| 30
| 0.840942
| 0.738892
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 8
| 97
| 10.199219
| 59
| 20
| 36.09375
| 195.21875
| 3.099609
| 0.699951
| 4.899414
| 140
| 7.329102
| 178
| 59
| 1,300
| 3
| 5
|
no(M2 and SIP pres)
| 5
| 466
| 1
|
77.93799
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 8,357
| 5,456.5352
| 5,842.47656
| 11.5
|
black
| 16.5
| 22
| 0.860962
| 0.770996
| 1
| 0
| 1
|
no
| 0.8
| 0.6
|
no dnr
| 8
| 113
| null | 76
| 20
| 36.5
| null | null | null | 1.099854
| 146
| null | 65
| 16
| null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 773
| 0
|
53.85898
|
female
| 1
| 5
|
Coma
|
Coma
| 0
| 12
| null | 0
| 41,029
| 26,436.7656
| 29,938.9844
| 61
|
black
| 15.398438
| 25
| 0.838989
| 0.806885
| 8
| 0
| 0
|
no
| 0.8
| 0.9
|
no dnr
| 5
| 116
| 19.199219
| 62
| 18
| 35.59375
| 390.4375
| 4.399414
| 0.699951
| 0.799927
| 133
| 7.259766
| 330
| 18
| 3,400
| null | null |
<2 mo. follow-up
| 1.609131
| 5
| 1
|
74.46698
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 17
|
>$50k
| 0
| 16,886
| 9,589
| 10,968.9297
| 30
|
white
| 34.898438
| 68
| 0.53894
| 0.340942
| 1
| 1
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 11
| 67
| 9.5
| 116
| 12
| 35.59375
| 344
| null | null | 1.399902
| 112
| 7.459961
| 168
| 16
| 2,128
| null | 0
| null | 0
| 634
| 1
|
48.181
|
male
| 1
| 67
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 121,285
| 82,648
| 90,871.0625
| 16.25
|
white
| 28.597656
| 38
| 0.727905
| 0.643921
| 21
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 58
| 72
| 12.5
| 50
| 24
| 36.19531
| 282
| 4.199219
| 0.699951
| 1.599854
| 141
| 7.299805
| 123
| 25
| 2,260
| 2
| null | null | 1.838867
| 67
| 1
|
49.96298
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 0
| 26,074
| 16,713.625
| 19,144.8281
| 16.5
|
white
| 33.796875
| 43
| 0.656982
| 0.55896
| 4
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 12
| 124
| 16.296875
| 180
| 37
| 38
| 367.5
| 2.299805
| 0.799927
| 0.899902
| 135
| 7.459961
| 114
| 29
| 2,024
| 0
| 3
|
no(M2 and SIP pres)
| 3
| 770
| 0
|
62.48297
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
|
under $11k
| 0
| 50,318
| 33,684.7812
| 35,248.0312
| 20.666656
|
white
| 32.796875
| 35
| 0.591919
| 0.483948
| 6
| 1
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 18
| 74
| 6.599609
| 72
| 16
| 38.09375
| null | 2.099609
| 4.899414
| 0.899902
| 138
| null | 91
| 4
| 1,750
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 769
| 0
|
41.37399
|
female
| 0
| 87
|
Coma
|
Coma
| 0
| 14
| null | 61
| 161,771
| 111,000.875
| 123,108.25
| 27
|
white
| 17.898438
| 16
| 0.697998
| 0.644897
| 7
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 87
| 72
| 11.599609
| 58
| 22
| 36.5
| null | 3.799805
| 0.899902
| 0.699951
| 140
| null | 91
| 11
| 475
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 769
| 0
|
68.73895
|
female
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 10
|
under $11k
| 0
| 51,447
| 32,388.7031
| 38,091.2188
| 51
|
black
| 56.296875
| 111
| 0.001
| 0
| 12
| 0
| 0
|
yes
| 0.05
| 0.05
|
dnr after sadm
| 3
| 45
| 26.699219
| 122
| 44
| 40.79688
| 305
| 2
| 1.699951
| 6
| 134
| 7.299805
| 73
| 76
| 0
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
32.26599
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 29,835
| 19,437.3906
| 22,718.9688
| 25.5
|
white
| 25.898438
| 34
| 0.85498
| 0.804932
| 4
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 11
| 114
| 5.5
| 60
| 20
| 36.19531
| null | 3.699707
| 1
| 1.399902
| 145
| null | 282
| 31
| null | null | 0
| null | 0
| 766
| 0
|
77.27594
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 26
| 13,611
| 8,746.2656
| 9,409.88281
| 15
|
white
| 29.796875
| 33
| 0.487976
| 0.28595
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 2
| 64
| 27.699219
| 77
| 34
| 36
| 55
| 1.899902
| 1.299805
| 2.599609
| 147
| 7.379883
| 90
| 62
| 1,123
| null | 1
|
SIP>=30
| 1
| 148
| 1
|
67.87396
|
female
| 0
| 10
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 11,873
| 8,039.5586
| 10,097.7969
| 14.5
|
black
| 11.599609
| 17
| 0.795898
| 0.567993
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
dnr after sadm
| 9
| 112
| 14.199219
| 74
| 32
| 36.39844
| 157.125
| 4.5
| 2.199707
| 2
| 140
| 7.459961
| 124
| 39
| 1,625
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 763
| 0
|
51.06598
|
female
| 0
| 13
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 10
|
under $11k
| 0
| 10,079
| 7,440.2852
| 9,969.3125
| 20.5
|
black
| 23.796875
| 44
| 0.719971
| 0.633911
| 1
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 2
| 143
| 16.5
| 72
| 10
| 38.5
| 221.65625
| 3.299805
| 1.799805
| 1.699951
| 142
| 7.459961
| 155
| 46
| 3,680
| 6
| 3
|
<2 mo. follow-up
| 3
| 58
| 1
|
52.99399
|
male
| 1
| 13
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 31,891
| 20,829.9844
| 24,705.5156
| 47
|
white
| 32.09375
| 45
| 0.601929
| 0.411987
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 10
| 118
| 6.899414
| 76
| 20
| 35.59375
| 381.625
| 4.099609
| 1.199951
| 1.599854
| 131
| 7.429688
| 120
| 55
| 1,450
| null | null |
<2 mo. follow-up
| 2.875977
| 13
| 1
|
50.26999
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 3,801
| 2,191.418
| 2,141.97852
| 4
|
black
| 21.296875
| 28
| 0.906982
| 0.843994
| 1
| 0
| 0
|
no
| 0.76
| 0.6
|
no dnr
| 4
| 97
| 12.599609
| 65
| 24
| 36.5
| 309.5
| 4.599609
| 2.5
| 1
| 136
| 7.40918
| 103
| 18
| 2,000
| 2
| 3
|
no(M2 and SIP pres)
| 3
| 397
| 1
|
46.86398
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 3,070
| 2,063.2363
| 2,431.10938
| null |
black
| 9.599609
| 9
| 0.853882
| 0.675903
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 3
| 128
| 9.599609
| 110
| 60
| 39.29688
| 98.5625
| 1.399902
| 1.099854
| 0.599976
| 138
| 7.40918
| 121
| 4
| 4,730
| 0
| 2
|
SIP>=30
| 2
| 513
| 1
|
74.75195
|
female
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 7
|
under $11k
| 0
| 7,948
| 5,618.1289
| 7,480.72656
| 5
|
white
| 19.296875
| 8
| 0.572998
| 0.378967
| 1
| 1
| 0
|
metastatic
| 0.4
| 0.3
|
dnr after sadm
| 2
| 142
| 5.199219
| 70
| 24
| 35.89844
| 323.75
| 3.899902
| 0.899902
| 1.299805
| 144
| 7.459961
| 172
| 30
| 1,350
| 0
| null | null | 0.494751
| 78
| 1
|
60.33099
|
male
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
| null | 9
| 103,796
| 66,242.3125
| 78,435.375
| 44.333313
|
white
| 28.296875
| 53
| 0.728882
| 0.644897
| 1
| 1
| 0
|
no
| 0.6
| 0.6
|
dnr after sadm
| 20
| 67
| 9.5
| 110
| 32
| 35.79688
| null | 3.899902
| 0.899902
| 0.899902
| 138
| null | 149
| 9
| 850
| null | 5
|
<2 mo. follow-up
| 5
| 24
| 1
|
90.31598
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
under $11k
| 0
| 27,841
| 19,648.4531
| 20,654.6875
| 17.666656
|
white
| 19.597656
| 33
| 0.782959
| 0.711914
| 1
| 0
| 0
|
no
| 1
| 0.8
|
no dnr
| 23
| 58
| 11.398438
| 65
| 24
| 37.89844
| 152
| 2.199707
| 0.299988
| 0.599976
| 141
| 7.509766
| 121
| 20
| 2,005
| 7
| 6
|
adl>=4 (>=5 if sur)
| 6
| 759
| 0
|
64.56897
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 5,765
| 3,704.4961
| 4,495.51953
| 11
|
white
| 18.199219
| 32
| 0.684937
| 0.390991
| 1
| 0
| 0
|
metastatic
| 0.1
| 0
|
no dnr
| 4
| 143
| 23.5
| 128
| 32
| 36.19531
| 379.5625
| 2.699707
| 0.299988
| 0.799927
| 137
| 7.449219
| 104
| 14
| 3,655
| 1
| null | null | 1.166748
| 387
| 1
|
52.88199
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 7
|
under $11k
| 0
| 5,504
| 2,770.3203
| 3,449.53906
| 14
|
white
| 14.699219
| 31
| 0.928955
| 0.878906
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 119
| 21.5
| 115
| 8
| 38.19531
| 305.6875
| 2.099609
| 5.5
| 1.899902
| 149
| 7.459961
| 245
| 80
| 2,510
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 759
| 0
|
57.69498
|
female
| 1
| 12
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 11,371
| 7,853.918
| 10,265.3438
| 13
|
white
| 20.199219
| 17
| 0.658936
| 0.355957
| 1
| 0
| 0
|
metastatic
| 0.1
| 0
|
dnr before sadm
| 0
| 74
| 8.398438
| 110
| 28
| 36
| 376.1875
| 3
| 0.899902
| 0.699951
| 133
| 7.489258
| 107
| 7
| null | null | 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
75.14899
|
female
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 6
|
under $11k
| 37
| 81,821
| 56,451.2188
| 68,577.0625
| 42
|
white
| 32
| 73
| 0.327942
| 0.212982
| 9
| 1
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 38
| 58
| 11.398438
| 99
| 12
| 36.59375
| 126.25
| 2.799805
| 0.599976
| 1.5
| 139
| 7.389648
| 227
| 42
| 2,110
| null | 0
|
SIP>=30
| 0
| 140
| 1
|
70.28296
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 7
|
under $11k
| 0
| 3,537
| 2,384.1836
| 2,320.75977
| 14
|
white
| 11
| 13
| 0.918945
| 0.862915
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 4
| 122
| 30.296875
| 300
| 12
| 36.29688
| 225
| 2
| 0.299988
| 0.599976
| 138
| 7.389648
| 171
| 28
| 2,465
| 2
| null |
SIP>=30
| 1.838867
| 757
| 0
|
83.24194
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
| null | 0
| 42,356
| 24,962.9844
| 30,839.2188
| 15.666664
|
white
| 21.796875
| 28
| 0.758911
| 0.681885
| 2
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 20
| 59
| 6.799805
| 58
| 24
| 35.19531
| null | 2.599609
| 1.099854
| 2.399902
| 150
| null | 181
| 32
| 1,400
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 757
| 0
|
54.09998
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
|
$11-$25k
| 0
| 20,297
| 12,216.4219
| 13,503.5391
| 29
|
white
| 26.199219
| 60
| 0.812988
| 0.75
| 1
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 9
| 115
| 4.399414
| 69
| 24
| 36.39844
| null | 3.299805
| 0.599976
| 0.799927
| 140
| null | 85
| 15
| null | 2
| 5
|
SIP>=30
| 5
| 756
| 0
|
75.92297
|
female
| 0
| 20
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
| null | 0
| 43,953
| 28,345.7969
| 35,247.0938
| 35.333313
|
white
| 44.898438
| 69
| 0.125
| 0.056
| 1
| 0
| 0
|
yes
| 0
| 0
|
no dnr
| 20
| 113
| 6.599609
| 82
| 20
| 37
| null | 2.699707
| 0.799927
| 1
| 146
| null | 115
| 16
| 3,117
| null | 2
| null | 2
| 68
| 1
|
78.87994
|
male
| 0
| 57
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$25-$50k
| 0
| 99,342
| 62,509.9688
| 71,938
| 32
|
white
| 16.097656
| 45
| 0.827881
| 0.769897
| 7
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 57
| 42
| 20.699219
| 66
| 3
| 34.39844
| 86
| 3
| 0.599976
| 2
| 136
| 7.259766
| 111
| 29
| 10
| null | 0
|
no(M2 and SIP pres)
| 0
| 754
| 0
|
47.41699
|
female
| 0
| 39
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
>$50k
| 9
| 147,284
| 93,937.5625
| 110,033.688
| 47
|
white
| 19.796875
| 35
| 0.62793
| 0.524902
| 16
| 0
| 0
|
metastatic
| 0.25
| 0.1
|
dnr before sadm
| -1
| 68
| 12.199219
| 71
| 20
| 36.69531
| 352
| 2.599609
| 5.399414
| 1.099854
| 128
| 7.489258
| 107
| 18
| 2,750
| 0
| 0
|
SIP>=30
| 0
| 74
| 1
|
25.659
|
female
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
under $11k
| 41
| 50,963
| 31,926.7188
| 36,235.4688
| 54
|
white
| 24.898438
| 24
| 0.823975
| 0.764893
| 1
| 0
| 0
|
no
| 0.5
| 0.8
|
dnr after sadm
| 15
| 47
| 16.199219
| 66
| 24
| 36
| null | null | null | 1.599854
| 132
| null | 478
| 26
| 4,150
| null | 7
|
<2 mo. follow-up
| 7
| 16
| 1
|
68.27899
|
male
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 7
|
under $11k
| 44
| 56,443
| 37,968.6875
| 41,037.75
| 27.5
|
white
| 17.699219
| 43
| 0.773926
| 0.700928
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 35
| 58
| 15.199219
| 80
| 13
| 36
| 174.28125
| 2.199707
| 1.599854
| 3.199707
| 131
| 7.449219
| 144
| 158
| 400
| null | 3
|
no(M2 and SIP pres)
| 3
| 271
| 1
|
58.04199
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 3
|
under $11k
| 0
| 4,621
| 2,825.0508
| 3,046.22852
| 5
|
black
| 12.099609
| 22
| 0.934937
| 0.889893
| 1
| 1
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 4
| 70
| 6.299805
| 101
| 24
| 35.39844
| 360
| 3.899902
| 1.099854
| 2.5
| 136
| 7.40918
| 101
| 30
| 1,848
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 754
| 0
|
64.534
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 9,137
| 6,217.2305
| 5,990.59766
| 9
|
white
| 16.796875
| 19
| 0.894897
| 0.824951
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 10
| 126
| 21.199219
| 124
| 34
| 39.89844
| 278
| 3
| 1.099854
| 1.199951
| 133
| 7.599609
| 329
| 16
| 3,980
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 195
| 1
|
55.04999
|
male
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
$11-$25k
| 0
| 60,692
| 40,551.0312
| 47,640
| 35.75
|
white
| 25.796875
| 37
| 0.784912
| 0.713989
| 4
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 29
| 102
| 12.398438
| 77
| 14
| 37.89844
| null | 3
| 0.599976
| 0.799927
| 142
| null | 96
| 31
| null | null | 1
|
no(M2 and SIP pres)
| 1
| 752
| 0
|
59.39999
|
female
| 0
| 83
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 166,403
| 0
| 0
| 40.5
|
white
| 26.597656
| 50
| 0.814941
| 0.700928
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 83
| 93
| 13.099609
| 108
| 16
| 36.5
| 316
| 4
| 0.599976
| 1
| 139
| 7.359375
| 108
| 12
| null | 0
| 0
|
SIP>=30
| 0
| 751
| 0
|
83.92297
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null |
under $11k
| 26
| 9,448
| 6,874.3594
| 6,855.29688
| 18
|
black
| 23.5
| 45
| 0.649902
| 0.549927
| 1
| 1
| 1
|
no
| 1
| 1
|
no dnr
| 11
| 115
| 15.398438
| 113
| 34
| 38.09375
| null | 1.899902
| 0.799927
| 1.899902
| 147
| 7.359375
| 213
| 81
| 3,130
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 750
| 0
|
67.71497
|
male
| 0
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
$25-$50k
| 0
| 10,883
| 6,483.543
| 7,480.54688
| 40
|
white
| 28
| 49
| 0.524902
| 0.408997
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 3
| 73
| 4.699219
| 96
| 24
| 35.79688
| 588
| 3
| 6.199219
| 3.699707
| 140
| 7.319336
| 143
| 70
| 2,825
| null | 2
|
<2 mo. follow-up
| 2
| 26
| 1
|
57.35199
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| null |
under $11k
| 0
| 44,357
| 30,127.9531
| 33,057.5938
| 34
|
black
| 20.699219
| 53
| 0.81897
| 0.758911
| 21
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 83
| 6.599609
| 76
| 24
| 36.5
| 233.3125
| 3.399902
| 0.799927
| 1.099854
| 137
| 7.459961
| 201
| 14
| 1.199951
| null | null |
<2 mo. follow-up
| 3.221191
| 5
| 1
|
80.44397
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 9
|
under $11k
| 100
| 28,011
| 18,735.6094
| 20,484.6562
| 52
|
black
| 85.5
| 112
| 0
| 0
| 14
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 77
| 12.599609
| 129
| 30
| 36
| 296
| 2.799805
| 0.5
| 1
| 131
| 7.539062
| 96
| 10
| 2,800
| null | null |
<2 mo. follow-up
| 2.238281
| 4
| 1
|
65.59595
|
male
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
|
under $11k
| 0
| 83,233
| 55,499.1562
| 62,521.3438
| 33.333313
|
white
| 26.597656
| 38
| 0.622925
| 0.518921
| 16
| 0
| 0
|
yes
| 0.8
| 0.7
|
no dnr
| 23
| 83
| 6.099609
| 93
| 20
| 37.59375
| 376.1875
| null | 1.299805
| 2.199707
| 137
| 7.519531
| 112
| 45
| 1,325
| null | 6
| null | 6
| 499
| 1
|
77.98798
|
male
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 38,200
| 19,655.75
| 25,473.1406
| 54.5
|
white
| 40.695313
| 50
| 0.342957
| 0.22699
| 1
| 0
| 0
|
no
| 0.2
| 0.15
|
dnr after sadm
| 12
| 63
| 12.5
| 69
| 12
| 38.19531
| 275.6875
| 2.899902
| 0.699951
| 0.699951
| 127
| 7.469727
| 172
| 15
| 2,166
| null | null |
<2 mo. follow-up
| 2.849609
| 13
| 1
|
70.66095
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
under $11k
| 9
| 20,463
| 14,014.3594
| 15,503.6172
| 12.333328
|
white
| 22.097656
| 26
| 0.791992
| 0.723999
| 1
| 0
| 0
|
no
| 0.95
| 0.94
|
no dnr
| 19
| 109
| 26
| 80
| 10
| 36.5
| 303.3125
| 1.899902
| 9
| 1.199951
| 133
| 7.479492
| 67
| 29
| 1,219
| 1
| null | null | 1.166748
| 748
| 0
|
52.07098
|
male
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 10
|
under $11k
| 0
| 9,472
| 6,581.4414
| 6,515.38672
| 8
|
black
| 16.199219
| 39
| 0.855957
| 0.762939
| 3
| 0
| 0
|
no
| 0.6
| 0.45
|
no dnr
| 7
| 69
| 25.296875
| 112
| 11
| 39.59375
| 116
| 2.299805
| 0.299988
| 0.899902
| 144
| 7.419922
| 121
| 16
| 1,206
| 7
| null | null | 5.199219
| 89
| 1
|
67.07697
|
female
| 0
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 50,276
| 32,878.0312
| 40,735.4062
| 45.333313
|
white
| 35.5
| 63
| 0.496948
| 0.295959
| 1
| 0
| 0
|
yes
| 0.85
| 0.8
|
no dnr
| 22
| 80
| 10.798828
| 72
| 20
| 36.19531
| null | 3.599609
| 1.199951
| 1.699951
| 122
| null | 283
| 51
| 1,460
| 2
| 1
|
no(M2 and SIP pres)
| 1
| 746
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.